MENU
Saleye Pharmaceuticals develops cheaper alternatives to proprietary drugs. Its mission statement states that it wants to create affordable medicine for everyone and create a healthier world. Saleye releases a new and improved version of its pain-relieving drug, Fento. Within a week, Saleye receives many complaints stating that the drug is inducing hallucinations and in some cases triggering certain anxiety disorders. Saleye was caught off-guard as its animal and human trials did not reveal any side effects. Saleye deliberated over the decision to recall the drug for over a week and by the time it eventually did, it had lost millions in stocks. Where did Saleye fail?
Suggested Answer: D
Get Premium PCM Questions
as Interactive Web-Based Practice Test or PDF
Real Exam Format
Detailed Explanations
Instant Access
Get Your Practice Test
39 comments · newest first
ME
Merissa
11 months ago
Their mission statement sounds good, but actions speak louder!
FA
Fanny
11 months ago
They lacked proper control measures for sure.
GE
Geraldo
12 months ago
Hallucinations? That sounds a bit extreme...
CH
Chu
12 months ago
I think they prioritized profits over safety.
WI
Willodean
12 months ago
They definitely should've done larger trials!
RO
Roxanne
1 year ago
I wonder if they considered the target market before creating the drug. If they had, maybe they would have anticipated the potential for anxiety disorders in certain users.
KA
Kati
1 year ago
I feel like they prioritized profits over effective drugs. Their mission statement sounds good, but the delay in recalling Fento suggests they were more focused on financial loss than patient safety.
TA
Tamra
1 year ago
I'm not entirely sure, but maybe they didn't have control measures in place? I remember a case study that emphasized the importance of monitoring drug effects post-launch.
LA
Latrice
1 year ago
I think Saleye might have failed because they didn't conduct large-scale human trials. It seems like a crucial step that could have caught those side effects earlier.
HI
Hildred
1 year ago
I thought their mission statement was solid, but maybe it didn’t translate into their practices. It’s confusing how they missed these issues during trials.
JA
Janessa
1 year ago
This reminds me of a case study we did on a similar situation where a company prioritized profits. I wonder if that played a role in Saleye's decision-making.
YE
Yen
1 year ago
I’m not entirely sure, but I think they might have underestimated the need for large-scale human trials. That could explain the unexpected side effects.
LA
Lashawnda
1 year ago
I remember discussing the importance of control measures in drug development. It seems like Saleye really dropped the ball there.
CH
Charlette
1 year ago
I'm not totally sure about this one. I'll need to review the concepts around translation patterns and route patterns before deciding.
EM
Emiko
1 year ago
Hmm, I'm a bit unsure about this one. The options seem to cover different aspects of customer success, but I'm not sure which one is the "best" summary. I'll have to think this through.
DO
Douglass
1 year ago
If I recall correctly, the 0.0.0.0 address means any IP can connect, which is broader than just one specific IP like 1.2.3.4. But I'm not completely confident in that.
QU
Quentin
1 year ago
I think the answer is B - Saleye didn't have the proper control measures in place to catch these serious side effects before releasing the drug. Their animal and human trials were clearly not comprehensive enough.
LE
Leota
1 year ago
C) It did not consider the target market before creating its drug.
SC
Scot
1 year ago
B) It did not have control measures in place.
FA
Fabiola
1 year ago
A) It did not have an ethical mission statement.
SE
Sena
1 year ago
Haha, 'a healthier world'? More like a world of hallucinating patients! Saleye needs to go back to the drawing board and remember that 'affordable' doesn't mean 'cutting corners'.
SH
Sharan
1 year ago
C) It did not consider the target market before creating its drug.
BR
Brandon
1 year ago
B) It did not conduct large-scale human trials.
LE
Leota
1 year ago
A) It did not have control measures in place.
MA
Marge
1 year ago
This is a classic case of prioritizing profits over safety. Saleye should have put the wellbeing of patients first, instead of rushing an untested drug to market. Their mission statement rings hollow now.
MI
Mitzie
1 year ago
This is a classic case of prioritizing profits over safety. Saleye should have put the wellbeing of patients first, instead of rushing an untested drug to market. Their mission statement rings hollow now.
TE
Tegan
1 year ago
B) It did not conduct large-scale human trials.
TA
Tasia
1 year ago
A) It did not have control measures in place.
BR
Brandon
1 year ago
Saleye clearly dropped the ball on quality control and testing. Skimping on large-scale human trials was a huge oversight, and their greed for profits blinded them to the real-world consequences.
AH
Ahmed
1 year ago
D) It did not consider the target market before creating its drug.
LU
Lura
1 year ago
C) It prioritized profits over effective drugs.
CA
Callie
1 year ago
B) It did not conduct large-scale human trials.
NG
Nguyet
1 year ago
A) It did not have control measures in place.
HA
Hayley
1 year ago
C) It prioritized profits over effective drugs.
AN
Andra
1 year ago
B) It did not conduct large-scale human trials.
AD
Adolph
1 year ago
A) It did not have control measures in place.
BI
Billye
2 years ago
I agree with Colene. They should have had better monitoring in place to catch these side effects earlier.
CO
Colene
2 years ago
Yeah, it's really concerning. I think they failed because they didn't have control measures in place.
ME
Mertie
2 years ago
I can't believe Saleye Pharmaceuticals messed up with their new drug.